ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 249 filers reported holding ALKERMES PLC in Q2 2018. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,842,667 | +11.4% | 172,891 | +24.5% | 0.00% | 0.0% |
| Q2 2023 | $4,347,404 | +55.7% | 138,895 | +40.2% | 0.00% | 0.0% |
| Q1 2023 | $2,792,549 | +313.8% | 99,061 | +283.5% | 0.00% | – |
| Q4 2022 | $674,885 | -4.1% | 25,828 | -18.0% | 0.00% | – |
| Q3 2022 | $704,000 | -29.8% | 31,497 | -6.6% | 0.00% | – |
| Q2 2022 | $1,003,000 | -77.8% | 33,713 | -80.4% | 0.00% | -100.0% |
| Q1 2022 | $4,514,000 | -5.3% | 171,594 | -16.3% | 0.00% | 0.0% |
| Q4 2021 | $4,769,000 | -49.3% | 205,041 | -32.7% | 0.00% | -50.0% |
| Q3 2021 | $9,402,000 | -64.3% | 304,854 | -71.6% | 0.00% | -66.7% |
| Q2 2021 | $26,316,000 | +160.1% | 1,073,202 | +98.1% | 0.01% | +200.0% |
| Q1 2021 | $10,119,000 | +78.7% | 541,752 | +90.9% | 0.00% | +100.0% |
| Q4 2020 | $5,663,000 | +251.3% | 283,855 | +191.8% | 0.00% | – |
| Q3 2020 | $1,612,000 | +3.4% | 97,262 | +21.0% | 0.00% | – |
| Q2 2020 | $1,559,000 | +33.2% | 80,369 | -1.0% | 0.00% | – |
| Q1 2020 | $1,170,000 | -19.6% | 81,192 | +13.7% | 0.00% | – |
| Q4 2019 | $1,456,000 | -6.2% | 71,389 | -10.3% | 0.00% | – |
| Q3 2019 | $1,553,000 | -30.8% | 79,591 | -20.0% | 0.00% | -100.0% |
| Q2 2019 | $2,243,000 | +22.3% | 99,487 | +97.9% | 0.00% | 0.0% |
| Q1 2019 | $1,834,000 | +18.4% | 50,262 | -4.3% | 0.00% | 0.0% |
| Q4 2018 | $1,549,000 | -89.3% | 52,503 | -84.7% | 0.00% | -75.0% |
| Q3 2018 | $14,534,000 | +18.2% | 342,481 | +14.7% | 0.00% | 0.0% |
| Q2 2018 | $12,291,000 | -41.6% | 298,619 | -17.7% | 0.00% | -33.3% |
| Q1 2018 | $21,041,000 | +7.9% | 363,014 | +1.8% | 0.01% | 0.0% |
| Q4 2017 | $19,509,000 | +32.2% | 356,455 | +22.8% | 0.01% | +20.0% |
| Q3 2017 | $14,754,000 | -14.5% | 290,196 | -2.5% | 0.01% | -16.7% |
| Q2 2017 | $17,260,000 | +4.0% | 297,750 | +4.9% | 0.01% | +20.0% |
| Q1 2017 | $16,602,000 | +3.9% | 283,827 | -1.2% | 0.01% | -16.7% |
| Q4 2016 | $15,972,000 | +30.3% | 287,382 | +10.2% | 0.01% | +20.0% |
| Q3 2016 | $12,261,000 | +15.7% | 260,694 | +6.4% | 0.01% | +25.0% |
| Q2 2016 | $10,594,000 | +779.2% | 245,095 | +595.3% | 0.00% | – |
| Q1 2016 | $1,205,000 | -87.2% | 35,252 | -70.2% | 0.00% | -100.0% |
| Q4 2015 | $9,391,000 | +30.5% | 118,291 | -3.5% | 0.00% | +33.3% |
| Q3 2015 | $7,194,000 | +196.7% | 122,602 | +225.2% | 0.00% | +200.0% |
| Q2 2015 | $2,425,000 | -50.9% | 37,695 | -53.5% | 0.00% | 0.0% |
| Q1 2015 | $4,942,000 | -95.9% | 81,048 | -96.0% | 0.00% | -97.9% |
| Q4 2014 | $119,268,000 | +30.2% | 2,036,701 | -4.7% | 0.05% | +23.7% |
| Q3 2014 | $91,588,000 | -1.2% | 2,136,461 | +16.0% | 0.04% | 0.0% |
| Q2 2014 | $92,728,000 | +25.6% | 1,841,958 | +10.0% | 0.04% | +22.6% |
| Q1 2014 | $73,809,000 | +12.4% | 1,674,050 | +3.7% | 0.03% | +10.7% |
| Q4 2013 | $65,662,000 | +70.5% | 1,614,889 | +41.0% | 0.03% | +55.6% |
| Q3 2013 | $38,501,000 | +35.0% | 1,145,153 | +15.1% | 0.02% | +20.0% |
| Q2 2013 | $28,528,000 | – | 994,632 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |